Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved.
The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®.
MS-8
NCCN Guidelines Index
Breast Cancer Table of Contents
Discussion
NCCN Guidelines Version 2.2015
Breast Cancer
and 82.9% of patients in the low-/intermediate-risk and high-risk arms,
respectively, with margin widths of ≥10 mm or no tumor on re-excision
observed in 48.5% and 53.3% of patients in the respective groups.
60
Although an acceptably low ipsilateral recurrence rate was observed in
the low-/intermediate-grade arm of the study at 5 years, the 7-year
ipsilateral recurrence rate in this group of patients was considerably
higher (10.5%; 95% CI, 7.5%–13.6%), suggesting that these events
may be delayed but not prevented in this population. Ipsilateral breast
recurrences were approximately equally divided between invasive
breast cancer and DCIS in the low-/intermediate-risk group but only
about one-third of patients with an in-breast recurrence in the high-risk
group had invasive disease.
Prospective randomized trials have not been carried out to analyze
whether wider margins can replace the need for radiation therapy for
DCIS. A retrospective series demonstrated that for margin width of 10
mm, radiation had no additional benefit in reducing the already low local
recurrence rate of 4% at the end of 8 years.
59
Also, if margin width was
between 1 mm and <10 mm, the addition of radiation therapy led to a
non-statistically significant reduction in local recurrence. However, when
margins were <1 mm a significant benefit was seen.
59
Another retrospective study reviewed 220 patients with DCIS treated
with breast conservation surgery and radiation. Thirty-six percent
received a radiation boost. At 46 months, none of the 79 patients who
received a radiation boost experienced a local recurrence, whereas 8 of
141 patients who did not receive a boost experienced a local
recurrence.
61
Many factors impact on recurrence risk, including patient age, tumor
size, tumor grade, and margin width. The definition of a negative margin
has not been firmly established in DCIS. There appears to be a
consensus that margins >10 mm are adequate and margins <1 mm are
inadequate, but no uniform consensus exists for margin status between
these values. Results from a retrospective study of 445 patients with
pure DCIS treated by excision alone indicated that margin width was the
most important independent predictor of local recurrence, although the
trend for decreasing local recurrence risk with increasing margin width
was most apparent with margins <1 mm and ≥10 mm.
62
In a
meta-analysis of 4660 patients with DCIS treated with
breast-conserving surgery and radiation, a surgical margin of <2 mm
was associated with increased rates of ipsilateral breast tumor
recurrence (IBTR) compared with margins of 2 mm, although no
significant differences were observed when margins of >2 mm to 5 mm
or >5 mm were compared with 2-mm margins.
63
The results of this study
suggest that wide margins (≥2 mm), which can compromise cosmetic
outcome, do not provide additional benefit in the population of patients
with DCIS receiving radiation therapy following breast-conserving
therapy. A large, retrospective study found that narrow surgical
resection margin (≤2 mm) does not increase local recurrence compared
to a surgical resection margin of 2 mm.
64
Further complicating the issue
of margin width is the impact of the fibroglandular boundary–the
pectoral fascia and the superficial skin where narrower tumor-free
margins may provide adequate local control.
A meta-analyses of four large multicentre randomized trials confirmed
the results of the individual trials that adding radiation therapy to breast
conserving surgery for DCIS provides a statistically and clinical
significant reduction in ipsilateral breast events (HR [hazard ratio],0.49;
95%CI; 0.41-0.58,
P
< .0000).
65
The choice of local treatment does not impact overall disease-related
survival; therefore, the individual patient’s acceptance of the potential
for an increased risk of local recurrence must be considered.